Post-approval studies (Phase 4)Study completedNCT02068365
What this trial is testing
An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue Therapy
Who this might be right for
Chronic Hepaititis B
Chinese University of Hong Kong 41